← All trials
NCT05384821
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2022
- Primary completion
- Jan 31, 2027
- Completion date
- Jan 31, 2028
- First posted
- May 20, 2022
- Last posted
- May 20, 2022
- Enrollment
- 28
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LilleLead sponsor
- University of LilleOverall official - principal investigator
- CHU La TimoneOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.